Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors.

Ciprian L, Lo Nigro A, Rizzo M, Gava A, Ramonda R, Punzi L, Cozzi F.

Rheumatol Int. 2013 Jan;33(1):241-5. doi: 10.1007/s00296-011-2147-9. Epub 2011 Sep 27.

PMID:
21947374
[PubMed - indexed for MEDLINE]
2.

Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.

Madsen OR, Rytter A, Hansen LB, Suetta C, Egsmose C.

Clin Rheumatol. 2010 Aug;29(8):849-54. doi: 10.1007/s10067-010-1407-5. Epub 2010 Mar 21.

PMID:
20306214
[PubMed - indexed for MEDLINE]
3.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

PMID:
17651658
[PubMed - indexed for MEDLINE]
Free Article
4.

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

Lord PA, Farragher TM, Lunt M, Watson KD, Symmons DP, Hyrich KL; BSR Biologics Register.

Rheumatology (Oxford). 2010 Mar;49(3):563-70. doi: 10.1093/rheumatology/kep422. Epub 2009 Dec 23.

PMID:
20032223
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial.

Masiero S, Bonaldo L, Pigatto M, Lo Nigro A, Ramonda R, Punzi L.

J Rheumatol. 2011 Jul;38(7):1335-42. doi: 10.3899/jrheum.100987. Epub 2011 Apr 1.

PMID:
21459942
[PubMed - indexed for MEDLINE]
6.

Efficacy of incentive spirometer exercise on pulmonary functions of patients with ankylosing spondylitis stabilized by tumor necrosis factor inhibitor therapy.

So MW, Heo HM, Koo BS, Kim YG, Lee CK, Yoo B.

J Rheumatol. 2012 Sep;39(9):1854-8. doi: 10.3899/jrheum.120137. Epub 2012 Aug 1.

PMID:
22859343
[PubMed - indexed for MEDLINE]
7.

Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis.

Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Govoni M.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):1125-9.

PMID:
20074478
[PubMed - indexed for MEDLINE]
8.

Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs.

Spadaro A, De Luca T, Massimiani MP, Ceccarelli F, Riccieri V, Valesini G.

Joint Bone Spine. 2008 Jan;75(1):29-33. Epub 2007 Sep 24.

PMID:
18029218
[PubMed - indexed for MEDLINE]
9.

Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis.

Chou CT, Tsai CY, Liang TH, Chang TM, Lai CH, Wei CC, Chen KH, Lin SC, Yu CL, Liou LB, Luo SF, Lee CS, Hsue YT, Huang CM, Chen JH, Lai NS, Cheng HH, Cheng TT, Lai HM, Tsai WC, Yen JH, Lu LY, Chang CP.

Mod Rheumatol. 2010 Dec;20(6):580-7. doi: 10.1007/s10165-010-0334-2. Epub 2010 Aug 4.

PMID:
20683633
[PubMed - indexed for MEDLINE]
10.

Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients.

Lin Z, Gu J, He P, Gao J, Zuo X, Ye Z, Shao F, Zhan F, Lin J, Li L, Wei Y, Xu M, Liao Z, Lin Q.

Rheumatol Int. 2011 Feb;31(2):233-8. doi: 10.1007/s00296-009-1313-9. Epub 2009 Dec 13.

PMID:
20012866
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis.

Coates LC, Cawkwell LS, Ng NW, Bennett AN, Bryer DJ, Fraser AD, Emery P, Marzo-Ortega H.

Rheumatology (Oxford). 2008 Jun;47(6):897-900. doi: 10.1093/rheumatology/ken094. Epub 2008 Apr 10.

PMID:
18403400
[PubMed - indexed for MEDLINE]
Free Article
12.

The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.

Barkham N, Kong KO, Tennant A, Fraser A, Hensor E, Keenan AM, Emery P.

Rheumatology (Oxford). 2005 Oct;44(10):1277-81. Epub 2005 Aug 16.

PMID:
16105913
[PubMed - indexed for MEDLINE]
Free Article
13.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M.

Ann Rheum Dis. 2010 Jun;69(6):1065-71. doi: 10.1136/ard.2009.111187. Epub 2009 Sep 9.

PMID:
19740906
[PubMed - indexed for MEDLINE]
14.

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

Rudwaleit M, Van den Bosch F, Kron M, Kary S, Kupper H.

Arthritis Res Ther. 2010;12(3):R117. doi: 10.1186/ar3054. Epub 2010 Jun 16.

PMID:
20553600
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Functional changes in patients with spondylarthropathy. A controlled trial of the effects of short-term rehabilitation and 3-year follow-up.

Viitanen JV, Heikkilä S.

Rheumatol Int. 2001 Jul;20(5):211-4.

PMID:
11518042
[PubMed - indexed for MEDLINE]
16.

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.

Arends S, Brouwer E, van der Veer E, Groen H, Leijsma MK, Houtman PM, Th A Jansen TL, Kallenberg CG, Spoorenberg A.

Arthritis Res Ther. 2011 Jun 20;13(3):R94. doi: 10.1186/ar3369.

PMID:
21689401
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.

Gadsby K, Deighton C.

Rheumatology (Oxford). 2007 Mar;46(3):439-41. Epub 2007 Jan 25.

PMID:
17255137
[PubMed - indexed for MEDLINE]
Free Article
18.

Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis.

Mathieu S, Dubost JJ, Tournadre A, Malochet-Guinamand S, Ristori JM, Soubrier M.

Joint Bone Spine. 2010 Jan;77(1):50-2. doi: 10.1016/j.jbspin.2009.05.012. Epub 2009 Dec 22.

PMID:
20022785
[PubMed - indexed for MEDLINE]
19.

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.

Vander Cruyssen B, Ribbens C, Boonen A, Mielants H, de Vlam K, Lenaerts J, Steinfeld S, Van den Bosch F, Dewulf L, Vastesaeger N.

Ann Rheum Dis. 2007 Aug;66(8):1072-7. Epub 2007 Jan 29.

PMID:
17261531
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial.

Cozzi F, Podswiadek M, Cardinale G, Oliviero F, Dani L, Sfriso P, Punzi L.

Joint Bone Spine. 2007 Oct;74(5):436-9. Epub 2007 May 30.

PMID:
17590368
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk